Abstract
It has been suggested that antibodies to a colonocyte protein of 40 kD (an intestinal isoform of tropomyosin) are specifically found in the serum and mucosa of patients with ulcerative colitis, which has important pathogenic implications. This study isolated and purified tropomyosin from the colonic mucosa, but no specific binding to Following the first description of antimucin antibodies by Broberger and Perlman (1959) in patients with ulcerative colitis (UC), the possibility that autoimmune damage of the colonic epithelium is important in the pathogenesis of UC has attracted considerable attention.1 2 While there is certainly a weak epidemiological association between UC (but not Crohn's disease) and other well characterised autoimmune conditions,3 it remains unclear whether any of the antigens that have been so far described from in vitro studies are actually important in the pathogenesis of the condition.
The proposed colonic autoantibodies in UC fall into two groups. The first is the 'classic' antigoblet (antimucin) apart from a phosphate enema 90 minutes beforehand, and they were not sedated.
The colonic mucosa was washed under direct vision with 100 ml 0.9% (w/v) saline injected through the flush channel of an Olympus CF200HL videocolonoscope or flexible sigmoidoscope, with the patient positioned to ensure that the relevant colonic segment was in a dependent position. Great care was taken to aspirate any fluid encountered in the colon during insertion of the colonoscope, and washings were only performed during withdrawal of the instrument. The wash fluid was aspirated after two minutes through the suction channel, and immediately aliquoted into 10 ml 1 mMphenylmethylsulphonyfluoride to inhibit proteolysis. Immunoglobulins were either extracted immediately as described below, or the sample was frozen for up to two weeks at -70°C before extraction.
Precipitation of mucosal immunoglobulin from endoscopic washings To precipitate immunoglobulins, 50 ml of 50% (w/v) polyethylene glycol (PEG) 4000 were slowly added to 100 ml of mucosal washings while vortexing. This was centrifuged at 6000 g for 10 minutes at 4°C. The supernatant was discarded, and the pellet containing immunoglobulin was resuspended in 2 ml of 15% (w/v) PEG 4000; this was reprecipitated at 6000 g for 10 minutes at 4°C, dried, and finally resuspended in 1 ml 10 mM-TRISCl, 50 mM NaCl pH7.4, before recentrifugation at 6000 g for 10 minutes at 4°C to remove undissolved material. The supernatant from this (1 ml) was divided into 50 aliquots, and was found to be stable at -20°C for up to four months, however, each aliquot was only thawed once Western blots SDS poly (12-5%) acrylamide gels were run as described previously18 using a mini-V.8.10 electrophoresis system (BRL). Molecular weight markers (rabbit muscle myosin, 205 000; Escherichia coli P-galactosidase, 116 000; rabbit muscle phosphorylase B, 97 400; bovine serum albumin, 66 000; bovine erythrocyte carbonic anhydrase, 29 000; egg white lysozyme, 14 300; Sigma) were run in a separate lane at the edge of the gel. Protein samples (200 ,ug) from colonic mucosal biopsy specimens were prepared as described previously19 and were run in a single large well on each gel to achieve uniform separation of the proteins (Fig 1) . After electrophoresis, the gels were either stained with Coomassie Blue R, or transferred to Hybond C (Amersham) using the electroblot stack assembly (150 V, 1 hour) with 25 mM-TRIS HCI; 192 mM glycine, 10% (v/v) methanol (pH 8.3) transfer buffer. The blots were dried and a strip at each end was removed (Fig 1) and stained with India ink to ensure clean separation of the mucosal proteins and uniform transfer. Markers were also visualised in a separate narrow well on the edge of the gel by India ink staining. Between the end strips the blots of mucosal proteins were sectioned into 2 mm strips and processed.
Each strip of the mucosal protein blot was washed in PBS containing 0.05%-TWEEN 20, and blocked by incubation in 10% bovine serum albumin at room temperature for one hour. They were then washed again in PBS-TWEEN and incubated with different samples of serum (500 ,l1) or mucosal immunoglobulin (300 pl1) preparations at a dilution of 1 in 50 in separate test tubes for two hours. The strips were individually washed three times with 5 ml of PBS-TWEEN in each tube and then incubated with biotinylated antihuman IgG (Vector Laboratories, BA3080) or antihuman IgA (Vector Laboratories, BA3030) at dilutions of 1:1000 and 1:1500 respectively. After washing three more times in 5 ml PBS-TWEEN, bound immunoglobulin was detected on each strip by incubation with avidin-horseradish peroxidase complex for 30 minutes at 25°C (Vectastain Elite ABC, Vector Laboratories); unbound enzyme was washed off with PBS-TWEEN and the enzyme was detected using diaminobenzidine as a substrate.
Preparation of human colonic tropomyosin Tropomyosin was prepared by the method of Cummins and Perry20 from mucosal scrapings of human colon taken from four anterior resection specimens, at least 18 cm from the adenocarcinomas. The mucosal scrapings were homogenised in 15 ml 1M KC1 using a Dounce homogeniser (Kontes Glass, Vineland, NJ), with 10 strokes of the loose fitting and 10 strokes of the tight fitting pestle. Undissolved material was removed by centrifugation (Sorvall RC2B centrifuge, GSA rotor, 6000 g) and the supernatant was acidified to pH 4-6 and stirred at room temperature for one hour. The precipitate was subject to four (Fig 3) . In patients with UC and Crohn's disease there were fewer IgA bands present in a lower proportion of patients (Table I) corresponding to proteins of Mr 85 000, 76 000, 52 000, 46 000, 43 000, 38 000, 29 000, 28 000. As the blot was obtained from mucosal proteins run en bloc and sectioned into strips with both edges being stained from protein to ensure uniform transfer, these differences are not accounted for by inconsistencies in blotting efficiency. Table I (Fig 4) . No serum IgA binding to mucosal proteins from UC or primary sclerosing cholangitis/UC cases was seen (Table I) .
Mucosal wash IgG binding to normal colonic mucosal proteins -some faint protein bands were also detected through mucosal IgG binding to normal colonic mucosal proteins in the western blot (Fig 3) . These proteins corresponded to Mr 93 000, 83 000, 76 000, 45 000, 38 000, 31 000, 28000, and 29 600. None of these were exclusively seen in either UC or Crohn's disease; Table II (Table II) .
In positive control serum samples of patients with primary biliary cirrhosis protein clear bands of 70 000 or 45 000 were seen consistent with the known molecular weight of the mitochondrial M2 complex (26, Fig 5) .
The 38 000 molecular weight band was weakly seen in 12 of 20 patients with UC, 11 we isolated this protein from the normal human colonic mucosa and purified it to two bands of 37 000 and 39 000 on a polyacrylamind gel corresponding to the two subunits previously described20 that comigrated with commercially purified porcine tropomyosin and reacted on western blotting as a single band with antichicken tropomyosin monoclonal (Fig 6) . The purified human protein was then used as antigen in ELISA experiments. These showed no evidence for significantly increased anti-testinal tropomyosin titres in the serum (Fig 7) or mucosal antibody preparations (not shown) from patients with UC 30 The IgA bands seen in mucosal immunoglobulin preparations of control subjects and with lower frequency in inflammatory bowel disease patients are at the same molecular weight as proteins detected in western blots of commensal enterobacteria (Khoo and Macpherson, submitted data), and thus result from the presence of enterobacterial proteins in the mucosal preparations.
Of course it remains possible that our detection methods on western blotting may be insufficiently sensitive to detect either specific mucosal or serum antibodies, which are Positive controls shown for antitropomyosin antibody. There was no significant increase in binding in the UC or UC/primary sclerosing cholangitis groups.
important in UC because of low abundance proteins or low titres of specific antibody. It is also possible that specific binding might be obscured on the western blotting (for example, by running at the same position as endogenous immunoglobulins). These criticisms should not apply, however, to the experiments on the 40 kD human intestinal tropomyosin, where purified antigen is available for ELISAs. Furthermore, the washing method may not isolate mucosal antibodies that are tightly tissue bound (although in the case of the 40 kD antigen, immunohistochemistry has shown that it is on the lumunal surface and Das has previously suggested that it is easily washed off the colonocytes,14). Our results do not support the hypothesis19 that immunoglobulin localised on the apical epithelial surface in patients with active UC is directed against tropomyosin, however the identity of the antigen(s) and whether these are colonocyte or luminal proteins, remains unclear.
In summary our data have not confirmed the suggestion that the serum of most UC patients contain high antibody titres to the '40 kD' tropomyosin (colonic isoform), nor have we been able to detect anticolonocyte or antimucosal antibodies specific for UC. While the finding of anticolonocyte antibodies would not necessarily establish an autoimmune aetiology for UC, our data cast doubt on the specificity of such antibodies either in the serum or mucosa of UC patients.
